Faculty Opinions recommendation of Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.

Controlled Trial ◽

Lewy Bodies ◽

Double Blind ◽

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(10)70194-0 ◽

2010 ◽

Vol 9 (10) ◽

pp. 969-977 ◽

Cited By ~ 235

Author(s):

Murat Emre ◽

Magda Tsolaki ◽

Ubaldo Bonuccelli ◽

Alain Destée ◽

Eduardo Tolosa ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Lewy Bodies ◽

Double Blind ◽

Faculty Opinions recommendation of Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1163524.625263 ◽

2009 ◽

Author(s):

Leo Verhagen

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicentre Trial ◽

Lewy Bodies ◽

Double Blind ◽

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

The Lancet Neurology ◽

10.1016/s1474-4422(09)70146-2 ◽

2009 ◽

Vol 8 (7) ◽

pp. 613-618 ◽

Cited By ~ 280

Author(s):

Dag Aarsland ◽

Clive Ballard ◽

Zuzana Walker ◽

Fredrik Bostrom ◽

Guido Alves ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicentre Trial ◽

Lewy Bodies ◽

Double Blind ◽

P4-419: Memantine improves attention and verbal episodic memory in Parkinson's disease dementia and dementia with Lewy bodies: A double-blind, placebo-controlled multicentre trial

Alzheimer s & Dementia ◽

10.1016/j.jalz.2013.08.252 ◽

2013 ◽

Vol 9 ◽

pp. P890-P890 ◽

Cited By ~ 3

Author(s):

Keith Wesnes ◽

Dag Aarsland ◽

Clive Ballard ◽

Elisabet Londos

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Episodic Memory ◽

Multicentre Trial ◽

Lewy Bodies ◽

Double Blind ◽

Double Blind Placebo ◽

Verbal Episodic Memory

P1-067: AMBROXOL AS PHARMACOLOGICAL CHAPERONE TARGETING GBA1 AS A DISEASE MODIFYING TREATMENT FOR PARKINSON'S DISEASE DEMENTIA: A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Alzheimer s & Dementia ◽

10.1016/j.jalz.2018.06.069 ◽

2006 ◽

Vol 14 (7S_Part_5) ◽

pp. P296-P296

Author(s):

Stephen H. Pasternak ◽

Carolina Silveira ◽

Zhonghan Li ◽

Robert Bartha ◽

Michael Borrie ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Phase 2 ◽

Double Blind ◽

Pharmacological Chaperone ◽

Double Blind Placebo ◽

Disease Modifying ◽

Disease Modifying Treatment

Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial

BMC Neurology ◽

10.1186/s12883-019-1252-3 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 33

Author(s):

C. R. A. Silveira ◽

J. MacKinley ◽

K. Coleman ◽

Z. Li ◽

E. Finger ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Single Centre ◽

Double Blind ◽

Double Blind Placebo ◽

Disease Modifying ◽

Disease Modifying Treatment

Faculty Opinions recommendation of Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8286956.8718054 ◽

2011 ◽

Author(s):

Irene Litvan ◽

Rita Simoes

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Depressive Symptoms ◽

Controlled Trial ◽

Double Blind ◽

Pingchan granule for depressive symptoms in parkinson’s disease: A randomized, double-blind, placebo-controlled trial

Journal of Integrative Medicine ◽

10.1016/j.joim.2020.12.006 ◽

2020 ◽

Author(s):

Si-chun Gu ◽

Jie Zhou ◽

Qing Ye ◽

Can-xing Yuan

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Depressive Symptoms ◽

Controlled Trial ◽

Double Blind ◽

Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double-blind placebo-controlled trial

Movement Disorders ◽

10.1002/mds.21226 ◽

2007 ◽

Vol 22 (2) ◽

pp. 179-186 ◽

Cited By ~ 185

Author(s):

Christopher G. Goetz ◽

Philippe Damier ◽

Christine Hicking ◽

Eugene Laska ◽

Thomas Müller ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Double Blind ◽

A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

Movement Disorders ◽

10.1002/mds.23954 ◽

2011 ◽

Vol 27 (1) ◽

pp. 106-112 ◽

Cited By ~ 66

Author(s):

Fabrizio Stocchi ◽

Rupam Borgohain ◽

Marco Onofrj ◽

Anthony H.V. Schapira ◽

Mohit Bhatt ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Early Parkinson’S Disease